alexa Abstract | Immunohistochemical detection of P53 protein as a prognostic indicator in prostate carcinoma

Journal of Chemical and Pharmaceutical Research
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Original Articles Open Access


Mutations of the p53 tumor suppressor gene can result in unregulated cellular growth and have been implicated in numerous malignancies. The aim of our study was to evaluate the prognostic significance of p53 protein immunoreactivity for prostate cancer and to determine whether p53 immunoreactivity correlates with the Gleason tumor grade in primary adenocarcinoma. Prostate fragments were fixed in 10% neutral-buffered-formalin, paraffinembedded, sectioned and standard Hematoxylin–Eosin stained, then examined using histological grade (Gleason system). P53 expression was studied using immunohistochemistry with monoclonal antibody anti-p53 mutant, 1 : 100 (DO-7) on tissue samples obtained during transurethral resection, in 40 patients with prostate carcinoma: Staining was defined as positive for p53 whenever any specific nuclear staining was detected. We considered tumors to overexpress p53 protein only when strong nuclear staining was present. lmmunoreactivity (IR) was categorized semi-quantitatively from 0 to 10% = negative, 11% to 40% weak, 41% to 70% moderate and 71% to 100% strong. 7 of 40 (17,5%) tumors are strong nuclear staining, 18 of 40 (45,0%) are moderate, 10 of 40 (25,0%) are weak and 5 of 40 (12,5%) are negative. Results were then compared to Gleason score. lmmunohistochemical detection of mutant p53 appears not to be an independent predictor of progression.

To read the full article Peer-reviewed Article PDF image

Author(s): Bungaran Sihombing Jamaludin Djong Hon Cong Sanusi Ibrahimand Sumaryati Syukur


immunohistochemistry, prostate carcinoma, p53, Immunohistochemical detection

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version